Of more than 5,100 women diagnosed with breast cancer at Sri Lanka's National Cancer Institute in 2016 to 2020, two thirds had early-stage disease, and 59% of those with HER2-positive cancer received trastuzumab.
Published as "Demographic, tumour, and treatment characteristics of female patients with breast cancer in Sri Lanka; results from a hospital-based cancer registry". All women with invasive primary breast cancer diagnosed in 2016 to 2020 were identified from the breast cancer registry of the National Cancer Institute of Sri Lanka, which the authors say sees approximately 40% of all cancer patients in the country.
Most care follows guidelines, but four in ten women with HER2-positive breast cancer did not receive trastuzumab, and late diagnosis remains common.
Shares Apeksha Hospital Maharagama (National Cancer Institute Sri Lanka), Breast cancer (all types).
Shares Apeksha Hospital Maharagama (National Cancer Institute Sri Lanka), Breast cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/